This inventor holds 7 USPTO granted patents. Top assignees: Knoll Aktiengesellschaft, Basf Aktiengesellschaft, Laboratories Knoll, S.a.. Active years: 1976-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 84 
1 out of 10,816 
1 out of 1 Years Active: 1976-1998
Title: The Innovative Contributions of Jose Maria Berlanga in Cancer Research
Introduction
Jose Maria Berlanga, a prominent inventor based in Madrid, Spain, has made significant strides in the field of cancer treatment through his innovative pharmaceutical inventions. With a total of seven patents to his name, Berlanga's work focuses on developing novel compounds that are crucial in combating various malignancies. His dedication to research and development has opened new avenues for cancer therapies.
Latest Patents
Among his latest patents, Berlanga has developed bis-naphthalimides aimed at treating cancer. These compounds and their corresponding pharmaceutical compositions are articulated in the formula outlined in his patent, showcasing specific chemical components that play an essential role in cancer treatment. Additionally, he introduced dihydrodibenzisoquinolinediones, which consist of novel bis-1,2-dihydro-3H-dibenzisoquinoline-1,3-diones and their salts. This innovation, along with associated processes for their preparation and pharmaceutical applications, aims primarily at treating human solid tumor carcinomas.
Career Highlights
Throughout his career, Berlanga has contributed to esteemed organizations, including Knoll Aktiengesellschaft and Laboratorios Made, S.A. His tenure at these companies reflects his commitment to enhancing medical treatments through innovative pharmaceutical research. His extensive experience has not only bolstered his knowledge but has also positioned him as a notable figure within the scientific community.
Collaborations
Jose Maria Berlanga has collaborated with a number of accomplished individuals in the pharmaceutical and research sectors, including Miguel Fernandez Brana and Cristobal M Roldan. These collaborations have fostered a dynamic environment for innovation and the continuous advancement of cancer treatment methodologies.
Conclusion
With a robust portfolio of patents and collaborations, Jose Maria Berlanga stands out as an influential inventor in the realm of cancer research. His unique compounds and compositions have the potential to pave the way for effective cancer therapies, reflecting his ongoing commitment to innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile